Clinical Trial Update: A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A Phase 1 trial to assess the safety, tolerability, and pharmacokinetics of LBL-047 in healthy adults and in patients with Systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• LBL-047

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING